Richard Callison, MD
Vascular Neurology · Fort Pierce, FLNPI 1326253832
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $17,100 of the $27,624 with a category attached, or 61.9%. Stryker accounts for 88.9% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $16,916 and has fallen 99.1% since, to $147 in 2025.
Across 111 payments — averaging $248.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$25K
- Penumbra, Inc.$2K
- Corelink, LLC$616
- Microvention, Inc.$533
- Genentech USA, Inc.$113
- Imperative Care, Inc$51
- plus $54 from 3 others
Across 3 payments — averaging $900.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Stryker$3K
What the payments were for
- Consulting fees$17,10062%
- Travel & lodging$3,81814%
- Food & beverage$6,60024%
- Education$200%
- Entertainment$870%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 66 | $24,556 |
| Penumbra, Inc. | 30 | $1,702 |
| Corelink, LLC | 3 | $616 |
| Microvention, Inc. | 7 | $533 |
| Genentech USA, Inc. | 1 | $113 |
| Imperative Care, Inc | 1 | $51 |
| Cordis US CORP. | 1 | $21 |
| CSL Behring | 1 | $20 |
| Bausch Health US, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- WINGSPAN$17,534
- SURPASS EVOLVE$3,047
- TREVO$2,170
- GATEWAY$1,875
- TARGET$912
- UNIVERSAL NEURO 3$891
- AXS INFINITY LS$790
- NEURO$497
- Penumbra System$313
- NEUROFORM ATLAS$239
- Penumbra SMART Coil$197
- CATALYST$150
- Sofia$146
- AXS CATALYST 7$143
- POD$143
- FRED$142
- FRED Jr$142
- LVIS$137
- Sofia 6F-125cm STR$137
- Headway$137
How this compares
$27,624 in reported general payments places this provider in the 85th percentile of 40 vascular neurology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 34 | $30,603 |
| BrilintaTicagrelor | 13 | $6,902 |
| ClopidogrelClopidogrel Bisulfate | 98 | $932 |
| Levetiracetam | 12 | $634 |
| Atorvastatin Calcium | 38 | $414 |
| Gabapentin | 13 | $333 |
Paid to pharmacies, not to this prescriber.
Other vascular neurology in Fort Pierce
- Maxim MokinTampa$137K
- Robert MannelJacksonville Beach$92K
- Alexander SenetarSarasota$42K
- Amin AghaebrahimJacksonville$36K
- Miguel ChuquilinTallahassee$30K
- Farah FourcandVero Beach$11K
- John CasselTampa$10K
- William BurginTampa$9K
- Mehdi BouslamaFort Lauderdale$8K
- Ritesh KaushalHialeah$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.